RU2020121597A3 - - Google Patents

Download PDF

Info

Publication number
RU2020121597A3
RU2020121597A3 RU2020121597A RU2020121597A RU2020121597A3 RU 2020121597 A3 RU2020121597 A3 RU 2020121597A3 RU 2020121597 A RU2020121597 A RU 2020121597A RU 2020121597 A RU2020121597 A RU 2020121597A RU 2020121597 A3 RU2020121597 A3 RU 2020121597A3
Authority
RU
Russia
Application number
RU2020121597A
Other languages
Russian (ru)
Other versions
RU2020121597A (ru
RU2791469C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020121597A publication Critical patent/RU2020121597A/ru
Publication of RU2020121597A3 publication Critical patent/RU2020121597A3/ru
Application granted granted Critical
Publication of RU2791469C2 publication Critical patent/RU2791469C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Resins (AREA)
  • Detergent Compositions (AREA)
RU2020121597A 2017-12-01 2018-11-30 Способ получения 2-(5-метоксиизохроман-1-ил)-4,5-дигидро-1h-имидазола и его гидросульфата RU2791469C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20176085 2017-12-01
FI20176085 2017-12-01
PCT/FI2018/050864 WO2019106238A1 (en) 2017-12-01 2018-11-30 Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof

Publications (3)

Publication Number Publication Date
RU2020121597A RU2020121597A (ru) 2022-01-04
RU2020121597A3 true RU2020121597A3 (enExample) 2022-01-04
RU2791469C2 RU2791469C2 (ru) 2023-03-09

Family

ID=

Also Published As

Publication number Publication date
IL274931B2 (en) 2023-11-01
US20200308152A1 (en) 2020-10-01
RU2020121597A (ru) 2022-01-04
HRP20221247T1 (hr) 2022-12-09
WO2019106238A1 (en) 2019-06-06
CN111630049B (zh) 2023-06-20
BR112020010617A2 (pt) 2020-11-10
IL274931A (en) 2020-07-30
HUE059849T2 (hu) 2023-01-28
AU2018376872A1 (en) 2020-07-16
CN111630049A (zh) 2020-09-04
DK3717476T3 (da) 2022-09-05
EP3717476A1 (en) 2020-10-07
JP7339946B2 (ja) 2023-09-06
KR20200095519A (ko) 2020-08-10
US11352346B2 (en) 2022-06-07
SI3717476T1 (sl) 2022-10-28
LT3717476T (lt) 2022-09-26
AU2018376872B2 (en) 2023-12-07
IL274931B1 (en) 2023-07-01
JP2021504418A (ja) 2021-02-15
ZA202003981B (en) 2021-07-28
ES2927193T3 (es) 2022-11-03
PL3717476T3 (pl) 2022-11-21
KR102718536B1 (ko) 2024-10-21
PT3717476T (pt) 2022-08-23
CA3083734A1 (en) 2019-06-06
EP3717476B1 (en) 2022-08-03

Similar Documents

Publication Publication Date Title
BR122021024395A2 (enExample)
BR122022025811B8 (enExample)
BR122021023687A2 (enExample)
BR122021014832A2 (enExample)
BR122022003518A2 (enExample)
BR102017014430A2 (enExample)
BR202017006953U2 (enExample)
BR202017004898U2 (enExample)
BR102017003115A2 (enExample)
BR202017002937U2 (enExample)
BR202017002826U2 (enExample)
CN303999626S (enExample)
CN303993489S (enExample)
CN304005413S (enExample)
CN304005203S (enExample)
CN304004459S (enExample)
CN304003876S (enExample)
CN304003818S (enExample)
CN304002112S (enExample)
CH714881A1 (enExample)
CN304005964S (enExample)
CN303999580S (enExample)
CN303999391S (enExample)
CN303999099S (enExample)
CN303997901S (enExample)